Follow Us: Follow Prostate on Facebook Follow ProstateNet on Twitter Get the Prostate.net RSS feed

Category Archives: Prostate Cancer

  • Related Categories
    • No categories

Vigorous Exercise Lowers Risk of Prostate Cancer Progression

Scientists at the University of California, San Francisco (UCSF) believe they have discovered why vigorous exercise lowers the risk of prostate cancer progression. While previous studies have indicated that vigorous exercise is associated with a lower risk of prostate cancer progression, they did not identify why this benefit occurred. Now, a research team has identified… Continue Reading »


More about:

Is Proton Therapy for Prostate Cancer Safe?

Researchers at the University of Florida in Jacksonville, Fla. studied 211 men with low, intermediate, and high-risk prostate cancer who were treated with proton therapy, a type of external beam radiation therapy (EBRT) that delivers high doses of protons to a targeted area, which radiation oncologists can achieve using advanced imaging techniques that allow them… Continue Reading »


More about:

Cancer Warning for Proscar, Propecia, Avodart and Jayln

The U.S. Food and Drug Administration (FDA) last year issued a safety warning for drugs used to treat enlarged prostate glands saying there is an increased risk of developing high-grade prostate cancer.  The agency said the Warnings and Precautions section of labels on the 5-alpha reductase inhibitor (5-ARI) class of drugs is being revised to… Continue Reading »


More about:

Drinking Milk May Increase Prostate Cancer Risk

A new study led by Johanna E. Torfadottir from the University of Iceland analyzed 8,894 men that were born between 1907 and 1935 and came from different areas of Iceland where regular milk consumption varied based on availability in the area. They followed these men for 24 years. Their study results showed that those men… Continue Reading »


More about: , ,

Mediterranean Diet Gives Longer Life

Research has shown ever since the 1950s that a Mediterranean diet, based on a high consumption of fish and vegetables and a low consumption of animal-based products such as meat and milk, leads to better health. These results are supported by three further as yet unpublished studies into Mediterranean diets and their health effects: one… Continue Reading »


More about:

Does Hormone Therapy Increase Risk of Heart Attack?

Men with prostate cancer who are considering hormone therapy or who are already on hormone therapy may be encouraged by the results of a new study appearing in the Journal of the American Medical Association. The meta-analysis found that hormone therapy did not increase the risk of cardiovascular deaths, plus it showed a lower risk… Continue Reading »


More about:

Hormone Therapy and Blood Clot Risk for Prostate Cancer Patients

For men with prostate cancer who are being treated with hormone therapy, news of a potentially dangerous side effect of hormone therapy associated with their prostate cancer treatment suggests it’s time to talk to their doctor. A large study conducted by researchers at Memorial-Sloan Kettering Cancer Center found that older men with prostate cancer who… Continue Reading »


More about:

Red Meat Increases Prostate Cancer Risk

Recent studies show the increased association between red meat and prostate cancer including an increased risk of prostate cancer when meat was grilled at high temperatures. In addition, men who ate the most ground beef were 2.3 times more likely than men who ate none to have aggressive prostate cancer. Read more


More about:

Radionuclide Therapy for Prostate Cancer Treatment

For prostate cancer patients with bone metastases, repeated administrations of radionuclide therapy with Re-HEDP are shown to improve overall survival rates and reduce pain, according to new research published in the November issue of The Journal of Nuclear Medicine. Read more


More about:

MDV 3100 (Medivation and Astellas) For Prostate Cancer Treatment

Fast on the heels of five new prostate cancer drugs approved for patients with advanced disease in the past 18 months, a promising new drug, MDV3100 (Medivation and Astellas), should soon be approved by the FDA for patients who have failed hormone therapy and chemotherapy with docetaxel. “The clinical advancement of MDV3100 is one of… Continue Reading »


More about:

  • Advertisement

  • better300x172rev2bgif
    ADVERTISEMENT

  • Advertisement